TARP gamma-8-associated AMPA receptor antagonist (Rapport Therapeutics)

N/A

Report date: 2025/06/11 10:54:00

Base Information

Drug NameTARP gamma-8-associated AMPA receptor antagonist (Rapport Therapeutics)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionVoltage-dependent calcium channel gamma-8 subunit inhibitorsNeuroprotectants
TargetsVoltage-dependent calcium channel gamma-8 subunit
Therapy Area/IndicationsNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRapport Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesRapport Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNervous System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A